183 related articles for article (PubMed ID: 7876172)
1. Site-directed mutagenesis of P2U purinoceptors. Positively charged amino acids in transmembrane helices 6 and 7 affect agonist potency and specificity.
Erb L; Garrad R; Wang Y; Quinn T; Turner JT; Weisman GA
J Biol Chem; 1995 Mar; 270(9):4185-8. PubMed ID: 7876172
[TBL] [Abstract][Full Text] [Related]
2. Extracellular nucleotides act through P2U purinoceptors to elevate [Ca2+]i and enhance basic fibroblast growth factor-induced proliferation in sheep chondrocytes.
Kaplan AD; Kilkenny DM; Hill DJ; Dixon SJ
Endocrinology; 1996 Nov; 137(11):4757-66. PubMed ID: 8895344
[TBL] [Abstract][Full Text] [Related]
3. Discrimination by PPADS between endothelial P2Y- and P2U-purinoceptors in the rat isolated mesenteric arterial bed.
Ralevic V; Burnstock G
Br J Pharmacol; 1996 May; 118(2):428-34. PubMed ID: 8735648
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological selectivity of the cloned human P2U-purinoceptor: potent activation by diadenosine tetraphosphate.
Lazarowski ER; Watt WC; Stutts MJ; Boucher RC; Harden TK
Br J Pharmacol; 1995 Sep; 116(1):1619-27. PubMed ID: 8564228
[TBL] [Abstract][Full Text] [Related]
5. Ontogeny of P2-purinoceptors in the longitudinal muscle and muscularis mucosae of the rat isolated duodenum.
Brownhill VR; Hourani SM; Kitchen I
Br J Pharmacol; 1997 Sep; 122(2):225-32. PubMed ID: 9313929
[TBL] [Abstract][Full Text] [Related]
6. P2U receptor is linked to cytosolic Ca2+ transient and release of vasorelaxing factor in bovine endothelial cells in situ.
Miyagi Y; Kobayashi S; Nishimura J; Fukui M; Kanaide H
J Physiol; 1996 May; 492 ( Pt 3)(Pt 3):751-61. PubMed ID: 8734987
[TBL] [Abstract][Full Text] [Related]
7. Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor.
Schachter JB; Li Q; Boyer JL; Nicholas RA; Harden TK
Br J Pharmacol; 1996 May; 118(1):167-73. PubMed ID: 8733591
[TBL] [Abstract][Full Text] [Related]
8. Expression and regulation of P2U-purinergic receptor in human granulosa-luteal cells.
Tai CJ; Kang SK; Cheng KW; Choi KC; Nathwani PS; Leung PC
J Clin Endocrinol Metab; 2000 Apr; 85(4):1591-7. PubMed ID: 10770202
[TBL] [Abstract][Full Text] [Related]
9. Molecular recognition at purine and pyrimidine nucleotide (P2) receptors.
Jacobson KA; Costanzi S; Ohno M; Joshi BV; Besada P; Xu B; Tchilibon S
Curr Top Med Chem; 2004; 4(8):805-19. PubMed ID: 15078212
[TBL] [Abstract][Full Text] [Related]
10. A novel P2-purinoceptor expressed by a subpopulation of astrocytes from the dorsal spinal cord of the rat.
Ho C; Hicks J; Salter MW
Br J Pharmacol; 1995 Dec; 116(7):2909-18. PubMed ID: 8680724
[TBL] [Abstract][Full Text] [Related]
11. Two distinct P2 purinergic receptors, P2Y and P2U, are coupled to phospholipase C in mouse pineal gland tumor cells.
Suh BC; Son JH; Joh TH; Kim KT
J Neurochem; 1997 Apr; 68(4):1622-32. PubMed ID: 9084434
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of P2U-purinergic nucleotide receptor messenger RNA expression during in vitro differentiation of human myeloid leukocytes by phorbol esters or inflammatory activators.
Martin KA; Kertesy SB; Dubyak GR
Mol Pharmacol; 1997 Jan; 51(1):97-108. PubMed ID: 9016351
[TBL] [Abstract][Full Text] [Related]
13. Co-existence of P2Y-and PPADS-insensitive P2U-purinoceptors in endothelial cells from adrenal medulla.
Mateo J; Miras-Portugal MT; Castro E
Br J Pharmacol; 1996 Nov; 119(6):1223-32. PubMed ID: 8937727
[TBL] [Abstract][Full Text] [Related]
14. Purinoceptors: are there families of P2X and P2Y purinoceptors?
Abbracchio MP; Burnstock G
Pharmacol Ther; 1994; 64(3):445-75. PubMed ID: 7724657
[TBL] [Abstract][Full Text] [Related]
15. Purinoceptor-stimulated phosphoinositide hydrolysis in Madin-Darby canine kidney (MDCK) cells.
Yang CM; Tsai YJ; Pan SL; Tsai CT; Wu WB; Chiu CT; Luo SF; Ou JT
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):1-7. PubMed ID: 9228183
[TBL] [Abstract][Full Text] [Related]
16. P2-purinoceptor-mediated formation of inositol phosphates and intracellular Ca2+ transients in human coronary artery smooth muscle cells.
Strøbaek D; Olesen SP; Christophersen P; Dissing S
Br J Pharmacol; 1996 Aug; 118(7):1645-52. PubMed ID: 8842427
[TBL] [Abstract][Full Text] [Related]
17. Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling.
Costanzi S; Mamedova L; Gao ZG; Jacobson KA
J Med Chem; 2004 Oct; 47(22):5393-404. PubMed ID: 15481977
[TBL] [Abstract][Full Text] [Related]
18. P2 purinoceptors in cultured bovine middle cerebral artery endothelial cells.
Zhang H; Weir BK; Marton LS; Lee KS; Macdonald RL
J Cardiovasc Pharmacol; 1997 Dec; 30(6):767-74. PubMed ID: 9436816
[TBL] [Abstract][Full Text] [Related]
19. The diverse series of recombinant P2Y purinoceptors.
Barnard EA; Webb TE; Simon J; Kunapuli SP
Ciba Found Symp; 1996; 198():166-80; discussion 180-8. PubMed ID: 8879825
[TBL] [Abstract][Full Text] [Related]
20. Characterization of signaling pathways of P2Y and P2U purinoceptors in bovine pulmonary artery endothelial cells.
Chen BC; Lee CM; Lee YT; Lin WW
J Cardiovasc Pharmacol; 1996 Aug; 28(2):192-9. PubMed ID: 8856473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
